Amphotericin B Treatment in Visceral Leishmaniasis
Not Applicable
Completed
- Conditions
- Visceral Leishmaniasis
- Registration Number
- NCT00310505
- Lead Sponsor
- Banaras Hindu University
- Brief Summary
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
- Detailed Description
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Parasitologically proved kala-azar
Exclusion Criteria
- HIV positive serology
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Final cure rate at six months after the end of treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kala-azar Medical Research Center
🇮🇳Muzaffarpur, Bihar, India